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Background

 denoma detection rate (ADR) is considered
A
the primary measure of quality with
performance targets of ≥30% for men and
≥20% for women. Studies have shown a
3% reduction in CRC incidence and a 5%
reduction in mortality for each 1% increase
1
in ADR.
Other quality measures include withdrawal
time ≥ 6 minutes and ≥95% cecal intubation
1
rate with photo-documentation.
Bowel preparation can affect all quality
measures. A strong recommendation was
given to provide both oral and written
patient education instructions and
2
emphasize the importance of compliance.
Open access colonoscopy (OAC) is the
process by which a patient is referred
directly for colonoscopy, without a precolonoscopy office visit. This can lead to
decreased wait time which improves
3
adherence.
Several studies demonstrate no differences
in understanding or patient satisfaction
4
compared with having a prior office visit.
Studies have also shown no differences in
5
cancellation and no-show rates. One study
of 368 patients who underwent OAC
demonstrated 87% of patients to have
6
good or excellent bowel preparation.
A New York City-based study of screening
colonoscopy among African American and
Hispanic patients demonstrated OAC and
a bilingual patient navigator resulted in
successful completion in 66% of patients;
7
an improvement over baseline.

2

Methods

Objectives:
Determine patient-specific factors and
comorbidities which would preclude OAC
eligibility and therefore increase time to
screening colonoscopy
Identify any difference in quality parameters
between OAC eligible and ineligible patients
Study Design:
Retrospective chart review of screening
colonoscopies scheduled at our GI Clinic
from July 1, 2016 to June 30, 2018
Included only patients at average risk
undergoing initial screening colonoscopy
All patients seen at an office visit prior to
their procedure
Charts reviewed to determine eligibility
for OAC
Eligible patients were compared to ineligible
patients using ADR, preparation adequacy,
cecal intubation rate, and any procedure
related complications
Exclusion Criteria for OAC Pathway

 5 of 68 (66.2%) patients would have been eligible for OAC
4
Higher proportion of Hispanic patients (57%) enrolled, but
also statistically more likely to be eligible for OAC
Overall, no significant differences in quality indicators were
found between the groups
Individual factors found to be associated with inadequate prep:
1) NYHA class III CHF or worse*
4) Use of systemic
anticoagulant
2) CKD4-5
*also associated with incomplete
3) HgbA1c > 8%*
colonoscopy

 o association between the presence of an exclusion
N
criterion and ADR
No procedure-related complications
No difference in “no-shows” or cancellations – 22 overall, but
evenly distributed with 11 in each group

Age – Median (IQR)

17 (37.8%)

11 (47.8%)

Female

40 (58.82%)

28 (62.2%)

12 (52.2%)

Race

17 (73.9%)

Cecal Intubation

CKD4-5
(7)

HgbA1c >8%
(13)

Hemoglobin <9 g/dL
(5)

Hispanic

39 (57.35%)

29 (64.4%)

10 (43.5%)

Black

5 (7.35%)

5 (11.1%)

0

BMI ≥40
(7)

Supplemental Oxygen

Prior complications
of anesthesia (3)

Other

6 (8.82%)

4 (8.9%)

2 (8.7%)

Prior difficult intubation

Active ASCVD

Preferred Language

6 (8.8%)

3 (6.7%)

3 (13%)

Yes

62 (91.2%)

42 (93.3%)

20(87%)

Adenoma

35 (51.47%)

18 (40%)

17 (73.9%)

Spanish

32 (47.06%)

26 (57.8%)

6 (26.1%)

1 (1.47%)

1 (2.2%)

0

Other

5 (75%)

35 (77.8%)

16 (69.6%)

Yes

16 (23.53%)

10 (22.2%)

6 (26.1%)

1 (1.47%)

0

1 (4.3%)

Not Retrieved

TABLE 3. Comparison of quality indicators between eligible and ineligible patients.

Discussion

TABLE 2. Comparison of demographics between eligible and ineligible patients of the analysis sample.
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58 (85.3%)

0.457

18 (26.47%)
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Adequate

55 (51-58)

White

TABLE 1. Study exclusion criteria with incidence rates in parentheses.

6 (26.1%)

54 (50.5-57)

NYHA III CHF
or worse (4)

Use of systemic anticoagulant or
anti-platelet agent other than ASA (8)

4 (8.9%)

54 (51-57)
28 (41.18%)

 iterature on open access is robust, but
L
pathways involving trainees and evaluation
of exclusion criteria are less prevalent.
Our study demonstrates no significant difference
in quality indicators between the two groups, but
interestingly, the ADR for ineligible patients (27.3%)
was higher than that for eligible patients (22.2%).
No difference in “no-shows” or cancellations
between the groups, but unclear if this will
translate to the actual open access pathway.
Our study potentially identifies significant
predictors of low quality colonoscopy: NYHA
class III or IV CHF, CKD4-5, use of a systemic
anticoagulant, and uncontrolled diabetes (HgbA1c
8% or greater). Further studies are required to
confirm this finding.
Our exclusion criteria require further examination in
order to identify other potential risk factors or subpopulations at risk for low quality colonoscopy.
Despite no significant differences, the trends
also indicate that further evaluation is required to
determine the true value of a pre-colonoscopy
office visit to each patient.
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P Value
0.076

10 (14.71%)

P Value

Male

OAC Ineligible

Inadequate

OAC Ineligible
(n=23)

Gender

OAC Eligible

Preparation Adequacy

OAC Eligible
(n=45)

Moderate asthma
or worse (2)

Presence of AICD
or pacemaker (2)

Analysis Sample

Analysis Sample
(n=68)

Moderate COPD
or worse (5)

Non-ambulatory
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Results

